NAFDAC Mandates Bioequivalence Studies to Strengthen Drug Safety Standards
In a decisive move to enhance public confidence in generic medicines and align Nigeria’s pharmaceutical industry with global standards, the National Agency for Food and Drug Administration and Control (NAFDAC) has mandated bioequivalence studies for all generic drugs produced or imported into the country. This regulatory shift was announced by NAFDAC’s Director General, Professor Mojisola